References
Kitano A, Kobayashi K, Murai M, Tanaka Y, Katayama T, Yamamoto S. Study of experimental ulcerative colitis in the rabbit. Jpn J Gastroenterol 1978;75:1719–26.
Kitano A, Kobayashi K, Oshiumi H, Okawa K, Oka S, Ono T. Studies of experimental ulcerative colitis induced by carrageenan in the rabbit. Jpn J Gastroenterol 1981;78: 2104–11.
Kitano A, Matsumoto T, Hiki M, Hashimura H, Yoshiyasu K, Kobayashi K. Epithelial dysplasia of the rabbit colon induced by degraded carrageenan. Cancer Res 1986;46:1374–6.
Matsumoto T, Kitano A, Oshitani N, Obata A, Hiki M, Hashimura H, et al. Immunoglobulin-containing cells in the colonic mucosa of rabbits with carrageenan-induced colitis. Dis Colon Rectum 1988;31:723–9.
Kitano A, Matsumoto T, Tabata A, Obayashi M, Nakagawa M, Watanabe Y, et al. Anti-inflammatory effects of the betamethasone sodium phosphate enema on carrageenan induced colitis in the rabbit. Jpn J Gastroenterol 1993;90:24–31.
Kitano A, Matsumoto T, Nakamura S, Oshitani N, Obata A, Nagura H, et al. Multifunctional effects of anticomplementary agent K-76 on carrageenan-induced colitis in the rabbit. Clin Exp Immunol 1993;94:348–53.
Kitano A, Matsumoto T, Tabata A, Obayashi M, Nakagawa M, Yasuda K, et al. Anti-inflammatory effect of bucillamine on carrageenan-induced colitis in the rabbit. Int J Immunother 1994;10:135–43.
Morris GP, Rebeiro L, Herride MM, Szewczuk M, Edpew W. An animal model of chronic granulomatous inflammation of the stomach and colon [abstract]. Gastroenterology 1984;88:1332.
Kashiwazaki S, Shiokawa Y. Bucillamine: a new immunomodulator. Int J Immunother 1987;3:1–6.
Abe C. Clinical evaluation of immunomodulators. Int J Immunother 1985;1:7–10.
Matsuno H, Kitano T, Matsushita I, Tsuji H, Ochiai H. Immunopharmacological evaluation of bucillamine in rheumatoid arthritis. Drugs Exp Clin Res 1993;19:205–11.
Wallace JL, Wallace K, MacNaughton, Morris GP, Beck PL. Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease. Gastroenterology 1989;96:29–36.
Hayashi M, Matsunaga K, Okahara A, Mita S. Effect of bucillamine (SA96) on type II collagen induced arthritis in rats. J Rheumatol 1991;18:691–5.
Isozaki T, Kimura M, Ikegaya N, Arai T, Fujigaki Y, Hishida A, et al. Bucillamine (a new therapeutic agent for rheumatoid arthritis) induced nephrotic syndrome: a report of two cases and reviews of the literature. Clin Invest 1992;70:1036–42.
Rights and permissions
About this article
Cite this article
Kiano, A., Oshitani, N., Okabe, H. et al. Effect if bucillamine on the rat trinitrobenzene sulfonic acid induced model of colitis. Inflamm Res 45, 491–493 (1996). https://doi.org/10.1007/BF02311083
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02311083